市場調査レポート

商品コード

1454861

消化器系の健康市場

Digestive Health

出版日: 2024年07月26日
発行: Nicholas Hall Group of Companies
ページ情報: 英文 374 Pages
納期: 即納可能

価格

PDF (Site License)

GBP 11,800 2,324,364円

レポートPDFを同一所在地の事業所でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Global License)

GBP 15,000 2,954,700円

複数の海外支店を保有する大企業様向けに提案するライセンスです。レポートPDFを同一企業の全世界の方にご使用頂けるライセンスです。ご利用人数に制限はありません。100％子会社は同一企業とみなされます。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能です。

価格表記: GBPを日本円(税抜)に換算

本日の銀行送金レート: 1GBP=196.98円

全表示
概要
目次

概要

サンプル依頼リストに入れる

消化器系の健康と、さまざまな側面における腸内マイクロバイオームの役割は、コンシューマーヘルスケアで最もホットな話題のひとつです。消費者の間ですでに需要が確立され、さらなる発展が期待されるCHC市場のこのエキサイティングな分野に、市場開発者と消費者はますます関心を寄せています。バイオティクスファミリーの健康効果が広く受け入れられ、その効能を裏付ける科学的エビデンスの蓄積に裏打ちされた免疫力、体重管理、皮膚の健康はもちろん、心臓、脳、関節の健康など、ますます幅広いカテゴリーで新商品が発売され、市場は拡大に向かっています。

一方、制酸剤、ORT、緩下剤、消化酵素など、伝統的な消化器系疾患カテゴリー全体が、現代のペースの速いストレスの多いライフスタイル、消化器系疾患に対する消費者の理解の高まり、的を絞った発売活動、コビド後の世界における旅行への回帰といった要因によって牽引されています。

今後5年～10年で最も急成長するCHCカテゴリーのひとつになると予測される胃腸薬は、食物不耐症、二日酔い治療薬、水分補給ウェルネスなどの有望な主要ニッチを含め、今後の発展の鍵となる分野です。

当レポートは、主要10ヶ国市場を詳細に調査し、主要製品の売上、ブランドの実績、最新の開発、2033年までの長期予測などをまとめています。

Digestive Health and the role of the gut microbiome in multiple facets of health is one of the hottest topics in consumer healthcare. Marketers and consumers are increasingly switched on to this exciting area of the CHC market that already has established demand among consumers and is ripe for further development. With widening acceptance of the health benefits of "the biotics family", the market is primed to expand via new launches across an ever-widening range of categories, including heart, brain and joint health, not to mention immunity, weight management and skin health, backed by a growing body of scientific evidence supporting their efficacy.

Meanwhile, a whole swathe of traditional GIs categories, including antacids, ORTs, laxatives, digestive enzymes & more, are being driven by factors such as modern fast-paced stressful lifestyles, rising consumer understanding of digestive conditions, targeted launch activity and a return to travelling in a post-Covid world.

Forecast to be among the fastest-growing CHC categories in the next 5-10 years, Gastrointestinals is a key arena for future development, including promising key niches such as food intolerance, hangover cures and rehydration wellness.

By examining 10 core markets in detail (and additional key markets in brief), analysing brand performances and launch activity, our "Digestive Health" report aims to investigate the untapped potential in this important CHC category.

Key Features of the report:

An in-depth exploration of the CHC GIs & Probiotics market globally, including Antacids, Laxatives, Antidiarrhoeals, Liver & bile remedies, ORTs, Probiotics and more
Coverage of 10 major markets from around the world, with topline sales, brand performances, the latest developments, launches and promotional campaigns PLUS mini-profiles of additional markets
Very latest year-end 2023 sales from the
just-published DB6, our dedicated CHC sales database, plus historical growth rates back to 2019
Case studies of key brands, highlighting strategies and success factors, sales, NPD activity and consumer & HCP promotion
A dedicated chapter investigates what the future holds for Digestive Health, examining the latest research into the gut-brain axis and new areas of development
Forecast sales to 2024 & 2025 for all categories and countries, plus longer-term predictions to 2028 & 2033

The report features the latest end-2023 sales data from our dedicated DB6 database, including topline historical sales globally, by country and category, as well as individual brand performances, and long-term forecasts to 2028 and 2033.

Diving into the factors affecting the Gastrointestinals & Probiotics markets, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report sheds light on trends & developments across 10 in-depth country rofiles with insights and predictions, as well as shorter profiles of other key markets.

A dedicated chapter - Digestive Health: What Does the Future Hold? - interrogates likely scenarios for the biotics family (probiotics, prebiotics, synbiotics & postbiotics), including the latest research into the gut-brain axis, the expanding role of gut flora in health and exciting areas of development such as probiotics for mental health, custom probiotics and the gut-muscle axis.

Key questions investigated in this report:

What are the key differences from market to market in terms of growth drivers, consumer choices and competitive landscape?
Which marketers and brands stand out and why?
How will NPD benefit GIs & Probiotics in the years ahead?
What are the opportunities for e-commerce and digital marketing?
What new niches and demographics remain underserved?
What does the future hold for Digestive Health brands?

10 individual markets profiled in depth:

Mexico
Japan
UK
Brazil
USA

China
Italy
India
Germany
France

Categories covered in this report include:

Antacids
Antiflatulents
Laxatives
Antidiarrhoeals
Oral rehydration treatments
Antinauseants

Digestive enzymes
Liver & bile remedies
Antispasmodics & IBS remedies
Traditional digestive remedies
Probiotics*

*sales tracked under VMS in DB6.

Executive Summary

Brazil

Overview
Antacids
Antiflatulents
Laxatives
Oral rehydration treatments
Digestive enzymes
Liver & bile remedies
Antispasmodics & IBS remedies
Other gastrointestinals
Probiotics
Outlook, forecast & opportunities

China

Overview
Antacids
Laxatives
Antidiarrhoeals
Oral rehydration treatments
Antinauseants
Digestive enzymes
Liver & bile remedies
Other gastrointestinals
Probiotics
Outlook, forecast & opportunities

France

Overview
Antacids
Antiflatulents
Laxatives
Antidiarrhoeals
Antinauseants
Liver & bile remedies
Antispasmodics & IBS remedies
Other gastrointestinals
Probiotics
Outlook, forecast & opportunities

Germany

Overview
Antacids
Antiflatulents
Laxatives
Antidiarrhoeals
Oral rehydration treatments
Antinauseants
Digestive enzymes
Liver & bile remedies
Antispasmodics & IBS remedies
Other gastrointestinals
Probiotics
Outlook, forecast & opportunities

India

Overview
Antacids
Antiflatulents
Laxatives
Oral rehydration treatments
Digestive enzymes
Liver & bile remedies
Traditional digestive remedies
Probiotics
Outlook, forecast & opportunities

Italy

Overview
Antacids
Antiflatulents
Laxatives
Antidiarrhoeals
Antinauseants
Digestive enzymes
Liver & bile remedies
Antispasmodics & IBS remedies
Probiotics
Outlook, forecast & opportunities

Japan

Overview
Antacids
Antiflatulents
Laxatives
Antidiarrhoeals
Antinauseants
Liver & bile remedies
Antispasmodics & IBS remedies
Traditional digestive remedies
Probiotics
Outlook, forecast & opportunities

Mexico

Overview
Antacids
Antiflatulents
Laxatives
Antidiarrhoeals
Oral rehydration treatments
Antinauseants
Liver & bile remedies
Antispasmodics & IBS remedies
Other gastrointestinals
Probiotics
Outlook, forecast & opportunities

UK

Overview
Antacids
Antiflatulents
Laxatives
Antidiarrhoeals
Oral rehydration treatments
Antinauseants
Antispasmodics & IBS remedies
Probiotics
Outlook, forecast & opportunities

USA

Overview
Antacids
Antiflatulents
Laxatives
Antidiarrhoeals
Oral rehydration treatments
Antinauseants
Digestive enzymes
Liver & bile remedies
Other gastrointestinals
Probiotics
Outlook, forecast & opportunities

Markets in Brief

Poland
South Korea
Spain

The Future of Digestive Health

Overview
Definitions & NPD
The expanding probiotics market

Brand Case Studies

Dramamine
Dulcolax
Electrolit
Pepcid AC
Tums

消化器系の健康市場

Digestive Health

目次

エグゼクティブサマリー

ブラジル

中国

フランス

ドイツ

インド

イタリア

日本

メキシコ

英国

米国

市場概要

消化器系の健康の未来

ブランド事例

見通し